Annaswamy Raji
6PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 21, 2025
Clinical Trial: A Phase 2b Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals With Pre-Cirrhotic MASH.Annaswamy Raji, Ira Gantz, Michael Crutchlow
|Aug 28, 2020
Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency.Annaswamy Raji, Zhi Jin Xu, Raymond L H Lam
|Jul 24, 2020
The effects of ertugliflozin on β-cell function: Pooled analysis from four phase 3 randomized controlled studies.Silvina Gallo, Annaswamy Raji, Roberto A Calle
|Jul 11, 2020
Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials.Silvina Gallo, Roberto A Calle, Steven G Terra
|Jul 19, 2018
A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT-R study.Russell Scott, Jerry Morgan, Zachary Zimmer
|Jun 25, 2018
Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials.Annaswamy Raji, Jianmin Long, Raymond L H Lam
Pageof 1
